by Team Small News | Sep 29, 2025 | Aurobindo Pharma, Cipla, Lupin, Pharma, Sun Pharma
The Indian pharmaceutical industry is facing a complex global trade landscape, with contrasting developments in China and the US. China has reduced import duties on Indian pharma products by 30%, effectively enabling near-zero-cost access, providing a significant...
by Team Small News | Sep 29, 2025 | Aurobindo Pharma, Pharma, Sun Pharma, Zydus
Sun Pharma, Zydus, and three other pharmaceutical companies have issued recalls for their products in the US market. The recalls were initiated due to various reasons, including contamination, labeling issues, and deviations from manufacturing standards. Sun Pharma,...
by Team Small News | Sep 28, 2025 | Glenmark, Pharma, Sun Pharma, Zydus
Several Indian pharmaceutical companies are recalling medicines from the US market due to various issues, as reported by the US Food and Drug Administration (USFDA). The recalls are related to manufacturing problems, impurities, and labeling errors. Glenmark...
by Team Small News | Sep 28, 2025 | Glenmark, Pharma, Sun Pharma, Zydus
Several Indian pharmaceutical companies are recalling medicines from the US market due to various issues, including manufacturing problems, impurities, and labeling errors, as reported by the US Food and Drug Administration (USFDA). The recalls affect a range of...
by Team Small News | Sep 27, 2025 | Cipla, Pharma, Sun Pharma
India’s generic pharmaceutical companies are likely to continue business as usual despite US President Donald Trump’s 100% levy on pharmaceuticals. The tariff is targeted at branded and patented medicines, which may not directly impact generic companies....
by Team Small News | Sep 25, 2025 | Pharma, Sun Pharma
Dilip Shanghvi, the founder of Sun Pharmaceutical Industries (Sun Pharma), is one of India’s most prominent self-made billionaires. Born in 1955 in Amreli, Gujarat, Shanghvi grew up in Kolkata, where his father ran a small pharmacy shop. From a young age,...